Fora Capital, LLC Karuna Therapeutics, Inc. Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $667,869 - $1.32 Million	4,148 New	4,148 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $551,113 - $1.24 Million	4,452 New	4,452 $1 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $59,527 - $75,316	-554 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $52,884 - $73,726	554 New	554 $67 Million
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $214,928 - $330,756	-3,014 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $187,289 - $353,270	3,014 New	3,014 $336 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.